Brief: Adaptive Biotechnologies Q1 EPS USD -0.33
07/05/2024 21:06
May 07 (Reuters) - Adaptive Biotechnologies Q1 revenue USD 41.873 million vs. IBES estimate USD 38.8 million. * Q1 operating income USD -48.762 million vs. IBES estimate USD -47.9 million * Q1 operating expenses USD 90.635 million * Q1 net income USD -47.533 million vs. IBES estimate USD -50.1 million * Q1 adjusted EBITDA USD -28.2 million vs. IBES estimate USD -32.9 million
Recent news on Adaptive Biotechnologies
See all newsAdvisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Adaptive Biotechnologies Q2 revenue rises 22%, beats estimates